Abstract
Xanthene derivatives were synthesized and evaluated for their potential as trypanothione reductase (TryR) inhibitors and chloroquine (CQ) potentiating agents. Some derivatives displayed inhibitory activity against TryR comparable to known tricyclic anti-depressants. On the other hand a number of derivatives increased CQ accumulation and potentiating effects in a resistant strain of Plasmodium falciparum with one compound also displaying strong intrinsic antimalarial activity.
| Original language | English |
|---|---|
| Pages (from-to) | 2289-2296 |
| Number of pages | 8 |
| Journal | Tetrahedron |
| Volume | 59 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 24 Mar 2003 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 9,9-dimethylxanthenes
- Chloroquine potentiating agents
- Leishmaniasis
- Malaria
- Trypanosomiasis
- Trypanothione reductase inhibitors
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Exploring the potential of xanthene derivatives as trypanothione reductase inhibitors and chloroquine potentiating agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver